My Legacy Advisors’s AbbVie ABBV Stock Holding History

My Legacy Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.06M	Buy	5,412 +45	+0.8%	+$8.36K	0.38%	79
2025 Q1	$1.12M	Buy	5,367 +15	+0.3%	+$2.92K	0.43%	65
2024 Q4	$917K	Sell	5,352 -323	-6%	-$59.4K	0.36%	75
2024 Q3	$1.12M	Sell	5,675 -603	-10%	-$113K	0.44%	62
2024 Q2	$1.08M	Buy	6,278 +166	+3%	+$27.5K	0.34%	79
2024 Q1	$1.11M	Buy	6,112 +20	+0.3%	+$3.45K	0.37%	71
2023 Q4	$998K	Buy	6,092 +2,247	+58%	+$328K	0.36%	80
2023 Q3	$560K	Buy	3,845 +156	+4%	+$22.9K	0.23%	134
2023 Q2	$493K	Buy	3,689 +1,246	+51%	+$183K	0.19%	150
2023 Q1	$394K	Buy	+2,443	New	+$373K	0.17%	162

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

My Legacy Advisors's ABBV Position: Q2 2025 in Review

My Legacy Advisors increased its AbbVie (ABBV) stake by 0.84% in Q2 2025, buying an estimated $8.36K and bringing the position to 5,412 shares worth $1.06M. The position accounts for 0.38% of the portfolio, ranked #79.

My Legacy Advisors first reported a position in ABBV in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.12M in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

My Legacy Advisors held 5,412 shares of AbbVie worth $1.06M as of Q2 2025.
My Legacy Advisors bought 45 AbbVie shares in Q2 2025, an estimated $8.36K.
AbbVie made up 0.38% of My Legacy Advisors's portfolio in Q2 2025, its #79 holding.
My Legacy Advisors first reported a position in AbbVie in Q1 2023 and has held it in 10 quarters since.
My Legacy Advisors's AbbVie position peaked at $1.12M in Q1 2025.
3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on My Legacy Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.